Figure 5
Post-operative survival curves of SOX2-positive and -negative cases. Patients with SOX2-negative esophageal cancer show significantly shorter recurrence-free (a) and disease-specific survival (b) than those with SOX2-positive malignancy (P<0.001 and P=0.002, respectively).
